FindTrial
Sign In

Application of integrated detection system in molecular epidemiology and pathogenicity of liver cirrhosis patients with HDV infection

Application of integrated detection system in molecular epidemiology and pathogenicity of liver cirrhosis patients with HDV infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037552
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis D

Interventions

Case series:NO

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: HBsAg positive patients with liver cirrhosis and some healthy volunteers

Exclusion criteria

Exclusion criteria: Patients with immunosuppressant and low immunity were used.

Design outcomes

Primary

MeasureTime frame
HDV antibody;—

Countries

China

Contacts

Public ContactChen Xiaohua

Shanghai Sixth People's Hospital

chenxiaohua2000@163.com+86 18930172758

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026